Lowering cancer drug dose could open tumours to immunotherapy
By Alicia Bienkowski | Brain, Cancer, Cancer, Disease Area, Lab, Media Releases, Melanoma Discovery, Melonoma, News & Events, Research, Research Area, Systems Biology and GenomicsGroundbreaking research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer drugs at a hundred-fold lower dose than standard protocols could improve the…
1000 walkers raise over $1.45m for women’s cancer research
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Disease Area, Events, Fundraising, News & Events, Ovarian CancerTaking steps to reduce the devastating impact of cancer on women. Fast Facts On average 69,000 new cases of cancer are diagnosed in Australian women each year. One in two…
“Google map” of ovarian tumours reveals cancer cells control who gets into their neighbourhood
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Genetic Disease, Genetic Disease, Genome Biology and Genetic Diseases, Lab, News & Events, Ovarian Cancer, Research, TumoursPerth researchers find some ovarian cancer cells appear to tell immune system to stay away. “Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones” published in…
Predicting immunotherapy effectiveness in late-stage liver cancer
By Richard Schoonraad | Cancer, Cancer, Funding, Immunotherapy, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, ResearchBlood test could hold key to identifying who will respond to immunotherapy after researchers discover biomarkers in liver cancer tissue. Liver cancer researchers at the Harry Perkins Institute of Medical…
World melanoma expert exposes sailor’s skin cancer risk
By Richard Schoonraad | Cancer, Cancer, Immunotherapy, Melanoma, Melanoma Discovery, Melonoma, News & Events, ResearchPerth based cancer researcher Professor Jonas Nilsson regularly sees in his laboratory just how damaging sun exposure is to our skin as he investigates ways to treat melanoma, the most…
New biomarker predicts liver cancer recurrence and immunotherapy response
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Disease Area, Immunotherapy, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Research, Tumours, xOncofetal EcosystemAnalysis of the environment that surrounds liver cancer tumours has revealed that patients with a high concentration of a certain cell type have early return of aggressive cancer but do…
WA researchers excel in nationally competitive grants
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Cancer Epigenetics, Cardiovascular Disease, Cardiovascular Disease, Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases, Media Releases, Mitochondrial disease, Mitochondrial Disease, Mitochondrial Medicine and Biology, News & Events, Research, TranslationEight (8) Federal government grants awarded to the Harry Perkins Institute of Medical Research Two of Australia’s most significant research grants, given only to the nation’s highest performing researchers, have…
Australian Cancer Plan consultation period open
By Richard Schoonraad | Cancer, Cancer, Cancer Centre News, News & EventsFurther to the Federal Government commitment of $375M to establish the Perkins-led WA Comprehensive Cancer Centre, the Government has been consulting with stakeholders to develop the Australian Cancer Plan. This…